{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T01:19:43Z","timestamp":1775783983088,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009888","name":"Regione Toscana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Proteomics"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.jprot.2018.04.012","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T12:53:40Z","timestamp":1523451220000},"page":"44-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Putative salivary biomarkers useful to differentiate patients with fibromyalgia"],"prefix":"10.1016","volume":"190","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5851-9249","authenticated-orcid":false,"given":"Federica","family":"Ciregia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Giusti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Boldrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella","family":"Piga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna","family":"Consensi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Gori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Lucacchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria R.","family":"Mazzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Bazzichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jprot.2018.04.012_bb0005","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia. A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jprot.2018.04.012_bb0010","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s11916-013-0356-5","article-title":"Worldwide epidemiology of fibromyalgia","volume":"17","author":"Queiroz","year":"2013","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.jprot.2018.04.012_bb0015","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s40273-014-0137-y","article-title":"Fibromyalgia: disease synopsis, medication cost effectiveness and economic burden","volume":"32","author":"Skaer","year":"2014","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.jprot.2018.04.012_bb0020","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/01.rhu.0000221817.46231.18","article-title":"The incidence of fibromyalgia and its associated comorbidities: a population-based retrospective cohort study based on International Classification of Diseases, 9th revision codes","volume":"12","author":"Weir","year":"2006","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0025","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jprot.2018.04.012_bb0030","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jprot.2018.04.012_bb0035","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.3899\/jrheum.100594","article-title":"Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia","volume":"38","author":"Wolfe","year":"2011","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1002\/acr.22742","article-title":"Comparison of physician-based and patient-based criteria for the diagnosis of fibromyalgia","volume":"68","author":"Wolfe","year":"2016","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.jprot.2018.04.012_bb0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.jprot.2018.04.012_bb0050","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.3899\/jrheum.170095","article-title":"A comparative evaluation of the 2011 and 2016 criteria for fibromyalgia","volume":"44","author":"Ablin","year":"2017","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0055","doi-asserted-by":"crossref","first-page":"938576","DOI":"10.1155\/2014\/938576","article-title":"Unique cytokine signature in the plasma of patients with fibromyalgia","volume":"2014","author":"Sturgill","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jprot.2018.04.012_bb0060","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s00296-014-3172-2","article-title":"Cytokine and chemokine profiles in fibromyalgia, rheumatoid arthritis and systemic lupus erythematosus: a potentially useful tool in differential diagnosis","volume":"35","author":"Wallace","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jprot.2018.04.012_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.imlet.2014.01.009","article-title":"Fibromyalgia and cytokines","volume":"161","author":"Rodriguez-Pint\u00f3","year":"2014","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.jprot.2018.04.012_bb0070","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1586\/1744666X.2013.849440","article-title":"The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management","volume":"9","author":"Giacomelli","year":"2013","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0075","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1472-6890-12-25","article-title":"Unique immunologic patterns in fibromyalgia","volume":"12","author":"Behm","year":"2012","journal-title":"BMC Clin. Pathol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-0032-1309008","article-title":"Association between thyroid autoimmunity and fibromyalgia","volume":"120","author":"Suk","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"10.1016\/j.jprot.2018.04.012_bb0085","doi-asserted-by":"crossref","first-page":"e0121903","DOI":"10.1371\/journal.pone.0121903","article-title":"Identification of a MicroRNA signature for the diagnosis of fibromyalgia","volume":"10","author":"Cerd\u00e1-Olmedo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2018.04.012_bb0090","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1007\/s12035-016-0235-2","article-title":"Circulating microRNA profiles as liquid biopsies for the characterization and diagnosis of fibromyalgia syndrome","volume":"54","author":"Masotti","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0095","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00296-014-3139-3","article-title":"Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study","volume":"35","author":"Bjersing","year":"2015","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jprot.2018.04.012_bb0100","doi-asserted-by":"crossref","first-page":"e78762","DOI":"10.1371\/journal.pone.0078762","article-title":"Mannerkorpi K Profile of cerebrospinal microRNAs in fibromyalgia","volume":"8","author":"Bjersing","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2018.04.012_bb0105","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00296-010-1678-9","article-title":"Candidate gene studies of fibromyalgia: a systematic review and meta-analysis","volume":"32","author":"Lee","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jprot.2018.04.012_bb0110","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.maturitas.2013.05.004","article-title":"Fibromyalgia syndrome\u2014novel therapeutic targets","volume":"75","author":"Ablin","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.jprot.2018.04.012_bb0115","first-page":"S111","article-title":"A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia","volume":"31","author":"Bazzichi","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/1479-5876-11-243","article-title":"A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers","volume":"11","author":"Ciregia","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jprot.2018.04.012_bb0125","doi-asserted-by":"crossref","first-page":"R194","DOI":"10.1186\/ar3523","article-title":"Proteomic analysis of saliva: a unique tool to distinguish primary Sj\u00f6gren's syndrome from secondary Sj\u00f6gren's syndrome and other sicca syndromes","volume":"13","author":"Baldini","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jprot.2018.04.012_bb0130","doi-asserted-by":"crossref","first-page":"e207","DOI":"10.1515\/cclm-2014-0086","article-title":"A preliminary study on serum proteomics in fibromyalgia syndrome","volume":"52","author":"Ruggiero","year":"2014","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.jprot.2018.04.012_bb0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/JPR.S102275","article-title":"Specific proteins of the trapezius muscle correlate with pain intensity and sensitivity - an explorative multivariate proteomic study of the trapezius muscle in women with chronic widespread pain","volume":"9","author":"Olausson","year":"2016","journal-title":"J. Pain Res."},{"key":"10.1016\/j.jprot.2018.04.012_bb0140","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1002\/prca.200900076","article-title":"Detection of potential markers of primary fibromyalgia syndrome in human saliva","volume":"3","author":"Bazzichi","year":"2009","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.jprot.2018.04.012_bb0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pt.2010.07.004","article-title":"Is SELDI-TOF a valid tool for diagnostic biomarkers?","volume":"26","author":"Ndao","year":"2010","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2174\/1874210600903010074","article-title":"Applications of surface-enhanced laser desorption \/ionization time-of-flight (SELDI-TOF) mass spectrometry in defining salivary proteomic profiles","volume":"3","author":"Al-Tarawneh","year":"2009","journal-title":"Open Dent. J."},{"key":"10.1016\/j.jprot.2018.04.012_bb0155","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1002\/pmic.200600783","article-title":"Proteome analysis of whole saliva: a new tool for rheumatic diseases\u2013the example of Sj\u00f6gren's syndrome","volume":"7","author":"Giusti","year":"2007","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2018.04.012_bb0160","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1039\/C5MB00022J","article-title":"Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: a proteomic study","volume":"11","author":"Ciregia","year":"2015","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.jprot.2018.04.012_bb0165","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/pmic.200800045","article-title":"Increasing information from shotgun proteomic data by accounting for misassigned precursor ion masses","volume":"8","author":"Scherl","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.jprot.2018.04.012_bb0170","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1097\/JTO.0b013e31821e1c08","article-title":"Combined serum mesothelin and plasma osteopontin measurements in malignant pleural mesothelioma","volume":"6","author":"Cristaudo","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0175","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jn\/125.6.1529","article-title":"Brain iron, transferrin and ferritin concentrations are altered in developing iron-deficient rats","volume":"125","author":"Chen","year":"1995","journal-title":"J. Nutr."},{"key":"10.1016\/j.jprot.2018.04.012_bb0180","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ejcn.2009.149","article-title":"Association between serum ferritin level and fibromyalgia syndrome","volume":"64","author":"Ortancil","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.jprot.2018.04.012_bb0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","article-title":"CSF iron, ferritin and transferrin levels in restless legs syndrome","volume":"14","author":"Mizuno","year":"2005","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.jprot.2018.04.012_bb0190","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jprot.2018.04.012_bb0195","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10067-011-1888-x","article-title":"Serum iron and iron stores in non-anemic patients with fibromyalgia","volume":"31","author":"Mader","year":"2012","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.abb.2009.05.010","article-title":"Transferrin secretory pathways in rat parotid acinar cells","volume":"487","author":"Nashida","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jprot.2018.04.012_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000358783","article-title":"Antimicrobial defense systems in saliva","volume":"24","author":"van't Hof","year":"2014","journal-title":"Monogr. Oral Sci."},{"issue":"10","key":"10.1016\/j.jprot.2018.04.012_bb0210","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1211\/0022357011777792","article-title":"Human lactoferrin: a novel therapeutic with broad spectrum potential","volume":"53","author":"Weinberg","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.jprot.2018.04.012_bb0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-016-0385-8","article-title":"Alpha-enolase (ENO1) controls alpha v\/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis","volume":"10","author":"Principe","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0220","doi-asserted-by":"crossref","first-page":"e69354","DOI":"10.1371\/journal.pone.0069354","article-title":"Surface alpha-enolase promotes extracellular matrix degradation and tumor metastasis and represents a new therapeutic target","volume":"8","author":"Hsiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jprot.2018.04.012_bb0225","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1476-4598-13-65","article-title":"Alpha-enolase as a potential cancer prognostic marker promotes cell growth, migration, and invasion in glioma","volume":"13","author":"Song","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jprot.2018.04.012_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-015-0117-5","article-title":"Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K\/AKT pathway","volume":"8","author":"Fu","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0235","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1002\/1521-4141(200012)30:12<3575::AID-IMMU3575>3.0.CO;2-#","article-title":"Surface expression of a glycolytic enzyme, alpha-enolase, recognized by autoantibodies in connective tissue disorders","volume":"30","author":"Moscato","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0240","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.2013090987","article-title":"Glomerular autoimmune multicomponents of human lupus nephritis in vivo: \u03b1-enolase and annexin AI","volume":"25","author":"Bruschi","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0245","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S1568-9972(02)00028-9","article-title":"The targets of nephritogenic antibodies in systemic autoimmune disorders","volume":"1","author":"Migliorini","year":"2002","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jprot.2018.04.012_bb0250","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/ki.1993.97","article-title":"Alphaenolase: a novel cytosolic autoantigen in ANCA positive vasculitis","volume":"43","author":"Moodie","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.jprot.2018.04.012_bb0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.autrev.2006.10.004","article-title":"Alpha-enolase: a target of antibodies in infectious and autoimmune diseases","volume":"6","author":"Terrier","year":"2007","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jprot.2018.04.012_bb0260","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jneuroim.2009.11.014","article-title":"High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases","volume":"219","author":"Kimura","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jneuroim.2006.06.016","article-title":"Diversified serum IgG response involving non-myelin CNS proteins during experimental autoimmune encephalomyelitis","volume":"179","author":"Zephir","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0270","first-page":"1199","article-title":"Evaluation of some antioxidant enzyme activities (SOD and GPX) and their polymorphisms (MnSOD2 Ala9Val, GPX1 Pro198Leu) in fibromyalgia","volume":"18","author":"Akbas","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jprot.2018.04.012_bb0275","first-page":"20","article-title":"The role of oxidative stress in the relation between fibromyalgia and obstructive sleep apnea syndrome","volume":"21","author":"Yildirim","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jprot.2018.04.012_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mito.2015.01.010","article-title":"Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with fibromyalgia","volume":"21","author":"S\u00e1nchez-Dom\u00ednguez","year":"2015","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jprot.2018.04.012_bb0285","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1111\/bph.13907","article-title":"The Arg-Phe-amide peptide 26RFa\/glutamine RF-amide peptide and its receptor: IUPHAR review 24","volume":"174","author":"Leprince","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jprot.2018.04.012_bb0290","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3389\/fnins.2016.00549","article-title":"The neuropeptide 26RFa (QRFP) and its role in the regulation of energy homeostasis: a mini-review","volume":"10","author":"Chartrel","year":"2016","journal-title":"Front. Neurosci."}],"container-title":["Journal of Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391918301726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874391918301726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T11:59:22Z","timestamp":1761739162000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874391918301726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":58,"alternative-id":["S1874391918301726"],"URL":"https:\/\/doi.org\/10.1016\/j.jprot.2018.04.012","relation":{},"ISSN":["1874-3919"],"issn-type":[{"value":"1874-3919","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Putative salivary biomarkers useful to differentiate patients with fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Journal of Proteomics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jprot.2018.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}